Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Ph I/Ph II MLN0128 vs. Pazopanib in Pts w/ Locally Advanced/Unresectable and/or Metastatic Sarcoma

Protocol: ALLIANCE-A091304

Full Title

A Phase I/Randomized Phase II Study of MLN0128(TAK-228) vs. Pazopanib in Patients with Locally Advanced/Unresectable and/or Metastatic Sarcoma